• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CVS Health appoints Michael F. Mahoney to its Board of Directors

    9/21/23 6:45:00 AM ET
    $BSX
    $CVS
    Medical/Dental Instruments
    Health Care
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $BSX alert in real time by email

    WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE:BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.

    CVS Health (PRNewsFoto/CVS Health)

    "Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS Health," said CVS Health President and CEO Karen S. Lynch. "Adding a well-respected health care leader to our Board demonstrates our continued focus on strengthening our engagement with consumers to improve their health and well-being."

    Mahoney became the CEO of Boston Scientific Corporation in 2012 and became Chairman of the company's Board of Directors in 2016. With more than 45,000 global employees, Boston Scientific reaches over 33 million patients each year, providing a range of technologies and solutions that span cardiovascular interventions, structural heart, electrophysiology, endoscopy, neuromodulation, urology, and women's health.

    "We're extremely pleased to have Mike join the Board," said Roger N. Farah, Independent Chair of the Board of CVS Health. "His knowledge and insight will be a tremendous asset, as will his background in leading the development of innovative solutions for patients."

    Mahoney's career spans more than 25 years of success building market-leading medical device, capital equipment and health care IT businesses. Prior to Boston Scientific, he served as Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson. Mahoney previously was President and CEO of Global Healthcare Exchange, a leading medical supply chain solutions company. For the first 12 years of his career, he advanced through a series of leadership roles at General Electric Medical Systems, including as General Manager of its Healthcare Information Technology business.

    "CVS Health and Boston Scientific share many common goals, with a primary focus on making a real difference for the people and patients we serve," Mahoney said. "I hope that my experience within the health care industry will help me work with the Board and the management team to support and advance CVS Health's strategy."

    Mahoney serves on the Board of the Boys & Girls Club of Boston and as the chair of the Board of Governors of the Boston College Chief Executives Club. He previously served on the Board of Directors of Baxter International Inc., a multinational health care company. He earned his B.B.A. in Finance from the University of Iowa and his M.B.A. from Wake Forest University. He is married and has three children.

    About CVS Health

    CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

    Media contact

    Ethan Slavin

    860-273-6095

    Ethan.Slavin@CVSHealth.com

    Investor contact

    Larry McGrath

    800-201-0938

    InvestorInfo@CVSHealth.com 

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-appoints-michael-f-mahoney-to-its-board-of-directors-301934025.html

    SOURCE CVS Health

    Get the next $BSX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BSX
    $CVS

    CompanyDatePrice TargetRatingAnalyst
    Boston Scientific Corporation
    $BSX
    5/29/2026Outperform → Peer Perform
    Wolfe Research
    Boston Scientific Corporation
    $BSX
    5/28/2026$55.00Overweight → Equal Weight
    Wells Fargo
    Boston Scientific Corporation
    $BSX
    3/30/2026$88.00Strong Buy → Outperform
    Raymond James
    CVS Health Corporation
    $CVS
    3/12/2026$94.00Mkt Perform → Outperform
    Bernstein
    CVS Health Corporation
    $CVS
    10/14/2025$91.00Buy
    Goldman
    Boston Scientific Corporation
    $BSX
    10/3/2025Buy → Hold
    Erste Group
    Boston Scientific Corporation
    $BSX
    9/8/2025$125.00Perform → Outperform
    Oppenheimer
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    More analyst ratings

    $BSX
    $CVS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 1, 2024 - FDA Roundup: March 1, 2024

    For Immediate Release: March 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a letter of enforcement discretion for certain qualified health claims regarding the consumption of yogurt and the reduced risk of type 2 diabetes. The letter states that the FDA does not intend to object to the use of these claims, provide

    3/1/24 4:00:21 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of its ultimate parent, CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.)Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary of Ae

    6/5/26 4:35:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health recognized for technology that improves medication safety and patient care

    The company was awarded a 2026 Newsweek AI Impact AwardWOONSOCKET, R.I., May 29, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it has been recognized by Newsweek with the 2026 AI Impact Award in the AI Health Care category, specifically for Best Outcomes – Patient Care. The award recognizes CVS Health's AI-Driven Prescription Interpretation and Instruction Standardization technology, which embeds artificial intelligence directly into pharmacy dispensing workflows to help pharmacists improve medication safety and patient care across the company's national pharmacy network. "This recognition reflects our commitment

    5/29/26 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna launches Aetna Mental Health On Demand to provide real time access to care and ongoing support

    In the initial launch, Aetna clinicians connected with members in just 13 secondsHARTFORD, Conn., May 28, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE:CVS) today announced Aetna Mental Health On Demand to broaden access to care and give members greater control over their mental health journey. Beginning in 2027, Aetna members enrolled in the service will have real time access to care and a plan to receive ongoing support via the member website. "Navigating the mental health system can be difficult. Individuals may not even know how to get started or how to find the right provider. That's one reason why about 1 in 4

    5/28/26 4:01:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $BSX
    $CVS
    SEC Filings

    View All

    SEC Form S-8 filed by CVS Health Corporation

    S-8 - CVS HEALTH Corp (0000064803) (Filer)

    5/22/26 4:28:36 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form S-3ASR filed by CVS Health Corporation

    S-3ASR - CVS HEALTH Corp (0000064803) (Filer)

    5/22/26 4:27:23 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SD filed by Boston Scientific Corporation

    SD - BOSTON SCIENTIFIC CORP (0000885725) (Filer)

    5/21/26 4:16:28 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Newman Brian covered exercise/tax liability with 2,478 shares, decreasing direct ownership by 45% to 3,008 units (SEC Form 4) (withholding obligation)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/1/26 5:02:36 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP, Chief Medical Officer Compton-Phillips Amy covered exercise/tax liability with 7,618 shares, decreasing direct ownership by 44% to 9,557 units (SEC Form 4) (tax withholding)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/1/26 5:00:41 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Chairman, President & CEO Mahoney Michael F gifted 386,755 shares (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    6/1/26 4:18:00 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Boston Scientific downgraded by Wolfe Research

    Wolfe Research downgraded Boston Scientific from Outperform to Peer Perform

    5/29/26 8:06:22 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Boston Scientific downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Boston Scientific from Overweight to Equal Weight and set a new price target of $55.00

    5/28/26 8:45:02 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Boston Scientific downgraded by Raymond James with a new price target

    Raymond James downgraded Boston Scientific from Strong Buy to Outperform and set a new price target of $88.00

    3/30/26 8:15:23 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ludwig Edward J bought $202,914 worth of shares (3,580 units at $56.68), increasing direct ownership by 16% to 25,359 units (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    5/21/26 5:21:10 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Director Pegus Cheryl bought $99,987 worth of shares (1,770 units at $56.49) (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    5/21/26 5:21:12 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Director Habiger David C bought $251,098 worth of shares (4,450 units at $56.43), increasing direct ownership by 47% to 13,878 units (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    5/21/26 5:20:09 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $CVS
    Leadership Updates

    Live Leadership Updates

    View All

    CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5

    COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ -- CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System. Eric Thepaut Appointed Independent Chairman of the Board Eric Thepaut joins CathVision following his recent retirement from Boston Scientific Corporation (NYSE:BSX), where he serv

    12/10/25 4:00:00 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $BSX
    $CVS
    Financials

    Live finance-specific insights

    View All

    AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of its ultimate parent, CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.)Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary of Ae

    6/5/26 4:35:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    ARCTRUST Acquires Seven Property Net Lease Portfolio for Planned DST Offering

    Diversified portfolio of Pinnacle Bank, CVS Pharmacy, and NAPA Auto Parts properties expands ARCTRUST's net lease platform for 1031 exchange investors ARCTRUST Private Capital, the capital markets division of the ARCTRUST Group of Companies, announced today the acquisition of a seven property, single-tenant net lease portfolio comprised of two Pinnacle Bank locations, three CVS Pharmacy locations, and two NAPA Auto Parts locations across six states. The portfolio will be offered to accredited investors as a Delaware statutory trust (DST): ARCTRUST Exchange II DST. The seven property portfolio consists of approximately 51,192 net rentable square feet across a combined land area of around

    5/28/26 8:00:00 AM ET
    $CVS
    $GPC
    $PNFP
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Automotive Aftermarket
    Consumer Discretionary

    CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

    First quarter total revenues increased to $100.4 billion, up 6.2% year-over-yearFirst quarter GAAP diluted EPS of $2.30 and Adjusted EPS of $2.57Raising full-year 2026 guidance:GAAP diluted EPS guidance range to $6.24 to $6.44 from $5.94 to $6.14Adjusted EPS guidance range to $7.30 to $7.50 from $7.00 to $7.20Cash flow from operations guidance to at least $9.5 billion from at least $9.0 billionWOONSOCKET, R.I., May 6, 2026 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) today announced operating results for the three months ended March 31, 2026."CVS Health continues to provide what people want most from health care: a connected, convenient, cost-effective engagement experience across our u

    5/6/26 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $BSX
    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/13/24 5:02:40 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by Boston Scientific Corporation (Amendment)

    SC 13G/A - BOSTON SCIENTIFIC CORP (0000885725) (Subject)

    2/13/24 5:00:46 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care